期刊
CLINICAL INFECTIOUS DISEASES
卷 76, 期 3, 页码 E526-E529出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac512
关键词
COVID-19; therapeutics; anti-virals; nirmatrelvir-ritonavir; virology
We enrolled 7 individuals who experienced recurrent symptoms or antigen test conversion after treatment with nirmatrelvir-ritonavir. High viral loads were detected after rebound, lasting a median of 17 days after initial diagnosis. Three individuals had culturable virus for up to 16 days after initial diagnosis. No known resistance-associated mutations were found.
We enrolled 7 individuals with recurrent symptoms or antigen test conversion following nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log(10) copies/mL) were detected after rebound for a median of 17 days after initial diagnosis. Three had culturable virus for up to 16 days after initial diagnosis. No known resistance-associated mutations were identified.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据